The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.

Clinical advances in hematology & oncology : H&O

Volumn 6, Issue 10, 2008, Pages 742-750

  Mehra, Ranee ^a   Cohen, Roger B ^a   Burtness, Barbara A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

DRUG ANTAGONISM; HEAD AND NECK TUMOR; HUMAN; METABOLISM; REVIEW; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 58149234368     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)